CLINICAL_TRIALS
trial_result
· 2015-12-08
Clinical Trial Update: Study of Pemetrexed for Second-Line Pancreas Cancer [Phase 2]
Summary
A Phase 2 study of pemetrexed for second-line pancreatic cancer was terminated, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Georgetown University | Conditions: Pancreas Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-12-08